Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Morgillo F
,
De Vita F
,
Antoniol G
,
Orditura M
,
Auriemma PP
,
Diadema MR
,
Lieto E
,
Savastano B
,
Festino L
,
Laterza MM
,
Fabozzi A
,
Ventriglia J
,
Petrillo A
,
Ciardiello F
,
Barbarisi A
,
Iovino F
.
Abstract
Increased insulin-like growth factor (igf) signalling has been observed in breast cancer, including endocrine-responsive cancers, and has been linked to disease progression and recurrence. In particular, igf-1 has the ability to induce and promote lymphangiogenesis through the induction of vascular endothelial growth factor C (vegfc). In the present study, we analyzed serum and tumour samples from 60 patients with endocrine-positive breast cancer to determine the expression and the possible relationship of circulating igf-1, igf binding protein 3 (igfbp3), and vegfc with the presence of lymphatic metastasis and other immunohistochemical parameters. The analysis revealed a clear and significant correlation between high basal levels of igf-1, igfbp3, and vegfc and lymph node metastasis in endocrine-responsive breast cancer. In addition, expression of those molecules was significantly higher in breast cancer patients than in healthy control subjects. Those findings may enable more accurate prediction of prognosis in patients with breast cancer.
Björndahl,
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
2005, Pubmed
Björndahl,
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.
2005,
Pubmed
Butt,
The IGF axis and programmed cell death.
1999,
Pubmed
de Ostrovich,
Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo.
2008,
Pubmed
Dupont,
The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components.
2000,
Pubmed
Enholm,
Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.
2001,
Pubmed
Firth,
Cellular actions of the insulin-like growth factor binding proteins.
2002,
Pubmed
Gu,
Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases.
2008,
Pubmed
Iovino,
Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
2008,
Pubmed
,
Echinobase
Lee,
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
1997,
Pubmed
McColl,
Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.
2003,
Pubmed
Mester,
Proliferation of breast cancer cells: regulation, mediators, targets for therapy.
2008,
Pubmed
Mu,
Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
2009,
Pubmed
Muendlein,
Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer.
2013,
Pubmed
Sachdev,
Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer.
2006,
Pubmed
Shin,
Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival.
2007,
Pubmed
Sisci,
Crosstalk between IGF signaling and steroid hormone receptors in breast cancer.
2007,
Pubmed
Skobe,
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
2001,
Pubmed
Stacker,
Current strategies for modulating lymphangiogenesis signalling pathways in human disease.
2006,
Pubmed
Surmacz,
Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
2004,
Pubmed
Wilker,
Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion.
2005,
Pubmed
Worthington,
Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.
2010,
Pubmed
Yakar,
The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.
2005,
Pubmed
Yee,
The insulin-like growth factors and breast cancer--revisited.
1998,
Pubmed
Yu,
Role of the insulin-like growth factor family in cancer development and progression.
2000,
Pubmed
